About OrSense
OrSense is a company based in Petah Tikva (Israel) founded in 1996. OrSense has raised $33.2 million across 4 funding rounds from investors including Israel HealthCare Ventures, Star Ventures and unknown. OrSense offers products and services including NBM200 and SOLIS. OrSense operates in a competitive market with competitors including Withings, Ultrahuman, iHealth Labs, Oura and Aktiia, among others.
- Headquarter Petah Tikva, Israel
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Orsense Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$33.2 M (USD)
in 4 rounds
-
Latest Funding Round
$18 M (USD), Series B
May 02, 2011
-
Investors
Israel HealthCare Ventures
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OrSense
OrSense offers a comprehensive portfolio of products and services, including NBM200 and SOLIS.
Non-invasive device for measuring hemoglobin and vital signs accurately.
Cloud-based platform for measurements delivery and stock control.
People of OrSense
Unlock access to complete
Funding Insights of OrSense
OrSense has successfully raised a total of $33.2M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $18 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OrSense
OrSense has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Israel HealthCare Ventures, Star Ventures and unknown.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early & late stage sector-agnostic VC firm investing in the US, Asia and Middle East
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for OrSense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OrSense
Investment portfolio details for OrSense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OrSense
Detailed financials for OrSense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orsense Comparisons
Peer comparison for OrSense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OrSense
OrSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Withings, Ultrahuman, iHealth Labs, Oura and Aktiia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Connected devices for health, sleep, and activity monitoring are developed.
|
|
| Locked | Locked | Locked |
Metabolic health is tracked via devices and fitness platforms.
|
|
| Locked | Locked | Locked |
Personal healthcare devices for vital monitoring are designed and produced.
|
|
| Locked | Locked | Locked |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
|
| Locked | Locked | Locked |
Offers wearable technology for 24/7 blood pressure tracking and app-based data analysis.
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
Detailed competitors of OrSense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orsense
Complete news archive for OrSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OrSense
OrSense was founded in 1996 and raised its 1st funding round 5 years after it was founded.
OrSense is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.
Yoav Reisman is the current CEO of OrSense.
OrSense is a funded company, having raised a total of $33.2M across 4 funding rounds to date.
Founded in 1996 in Petah Tikva, Israel, OrSense operates in the medical device sector, focusing on patient monitoring solutions. Non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose, and other blood parameters are enabled through proprietary Occlusion Spectroscopy technology. Monitoring of SpO2, pulse rate, plethysmogram, and related vitals is supported. Systems are utilized in hospital operating rooms, recovery areas, intensive care units, outpatient facilities, and emergency services.
OrSense's top competitors include Withings, Ultrahuman and Oura.
OrSense offers NBM200 and SOLIS.
OrSense has 5 investors. Key investors include Israel HealthCare Ventures, Star Ventures, unknown, Tamar Ventures, and moital.